Chemistry spin-out Ziylo acquired by global healthcare company in $800m deal which could transform the treatment of diabetes 17 August 2018 School of Chemistry spin-out company Ziylo has been bought by global healthcare company Novo Nordisk in a deal which could be worth around $800 million.
Years iterator 20112012201320142015201620172018201920202021
View all news
Edit this page